Rare diseases often stem from genetic mutations. Some are due to a single gene mutation; others involve multiple genes and environmental influences. Understanding these diseases demands extensive study. Techniques like whole-genome sequencing, exome sequencing, and gene panel testing help identify genetic variations linked to rare conditions. Yet, interpreting this data is complex. Scientists must differentiate between mutations that cause disease and those that are harmless. This process is vital to improve the diagnosis and treatment of rare diseases.
High testing prices stand as a barrier for many patients. Whole-genome sequencing, necessary for pinpointing rare disease mutations, can be prohibitively costly. This limits access, especially where healthcare funds or insurance support falls short.
A shortage of genetic experts slows down the diagnosis process. Geneticists and counsellors are key for interpreting complex test results. Yet, their scarcity means longer waits for those needing their expertise.
Efforts to enhance the availability and reliability of genetic tests are underway. More comprehensive genetic panels are being developed. Steps to make testing more affordable are being taken to improve patient access. Additionally, artificial intelligence and machine learning technologies are being tapped to refine the interpretation of genetic data and boost diagnostic precision.
